NCT06308263 Tuvusertib (M1774) Human Mass Balance and Absolute Bioavailability Study (DDRIVER Solid Tumors 303) Status COMPLETED Phase PHASE1
NCT06307249 Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA Status RECRUITING Phase PHASE1
NCT06305247 A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06299761 Study of the RNR Inhibitor BBI-825 in Subjects With Tumors With Resistance Gene Amplifications Status TERMINATED Phase PHASE1
NCT06290388 Study of 23ME-01473 in Patients With Advanced Solid Malignancies Status TERMINATED Phase PHASE1/PHASE2
NCT06264921 A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors Status TERMINATED Phase PHASE1
NCT06259552 A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors Status RECRUITING Phase PHASE1
NCT06258330 Study of AM003 in Patients With Locally Advanced and Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT06249256 An Exploratory Study on the Treatment of Advanced Solid Tumors by Fast CAR T Cells Status RECRUITING Phase EARLY_PHASE1
NCT06248697 Exploratory Study of MSLN-CAR T Cells Secreting PD1/CTLA-4 Nanoantibody for the Treatment of Advanced Solid Tumors Status RECRUITING Phase EARLY_PHASE1
NCT06245330 A Phase I/II Study of AST-001 in Subjects With Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06245018 A Trial to Evaluate the Safety and Preliminary Efficacy of iNK in the Treatment of Subjects With Solid Tumor Status NOT_YET_RECRUITING Phase NA
NCT06241898 A First-in-human of Multiplle Doses of BB-1709 in Subjects With Locally Advanced/Metastatic Solid Tumors Status RECRUITING Phase PHASE1
NCT06239298 A Study of ZG005 Combined With Donafenib in Patients With Advanced Solid Tumor Status RECRUITING Phase PHASE1/PHASE2
NCT06237413 A Study of ZG2001 in Participants With KRAS Mutated Advanced Solid Tumours Status RECRUITING Phase PHASE1/PHASE2
NCT06234423 A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06234098 Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06220318 Assessment of the Safety and Efficacy of C019199 Plus Sintilimab in Participants With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2